Indivi is developing digital biomarkers and digital health technologies (DHT) and precision measurements to accelerate neuroscience drug development and personalized care in neurodegenerative and neuroimmune diseases.
Indivi has raised €16M across 1 funding round from 1 investor, most recently a round in Nov 2025. Based in Basel, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-11-19 | Other | €16M |
| Ava Investors |
| View deal → |
